- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration ; volume:8 ; number:1 ; day:2 ; month:10 ; year:2013 ; pages:1-9 ; date:12.2013
Molecular neurodegeneration ; 8, Heft 1 (2.10.2013), 1-9, 12.2013
- Contributor
-
Desikan, Rahul S.
Thompson, Wesley K.
Holland, Dominic
Hess, Christopher P.
Brewer, James B.
Zetterberg, Henrik
Blennow, Kaj
Andreassen, Ole A.
McEvoy, Linda K.
Hyman, Bradley T.
Dale, Anders M.
SpringerLink (Online service)
- DOI
-
10.1186/1750-1326-8-39
- URN
-
urn:nbn:de:1111-2016073072180
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Desikan, Rahul S.
- Thompson, Wesley K.
- Holland, Dominic
- Hess, Christopher P.
- Brewer, James B.
- Zetterberg, Henrik
- Blennow, Kaj
- Andreassen, Ole A.
- McEvoy, Linda K.
- Hyman, Bradley T.
- Dale, Anders M.
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders